Ayşe Salihoğlu

Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion

Ahmet Emre Eşkazan, Deniz Eyice Karabacak, Enes Ali Kurt et al. · Leukemia Research · 2014 · 34 citations

Hematological Malignancy, Oncology, Mixed-phenotype Acute Leukemia +9

Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey

Ayşe Salihoğlu, Tuğrul Elverdi, Ìhsan Karadoǧan et al. · Annals of Hematology · 2014 · 33 citations · Full text

An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality

Ritvan Kara Ali, Serkan Sürme, İ̇lker İnanç Balkan et al. · Annals of Hematology · 2020 · 32 citations

Resistance Profiles, Health Sciences, Antibiotics +12

Successful management of cryoglobulinemia-induced leukocytoclastic vasculitis with thalidomide in a patient with multiple myeloma

Muhlis Cem Ar, Teoman Soysal, Gülen Hatemi et al. · Annals of Hematology · 2005 · 26 citations

Hematological Malignancy, Bone Marrow Failure, Hematology +5

Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec

Ahmet Emre Eşkazan, Sevil Sadri, Dilek Keskin et al. · Clinical Lymphoma Myeloma & Leukemia · 2017 · 25 citations

Hematological Malignancy, Early Molecular Response, Oncology +10